🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Guoliang Cui

University of Science and Technology of China

ORCID: 0000-0001-5559-7957

Also affiliated with German Cancer Research Center, Heidelberg University

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: Tetramethylpyrazine attenuates the cancer stem cell like-properties and doxorubicin resistance by targeting HMGCR in breast cancer.

3 citations

Manli Wang, Guoliang Cui, Yuanyuan Wu, Zhonghong Wei, Suyun Yu +6 more

52 citations

Nina Weisshaar, Agnes Hotz‐Wagenblatt, Alaa Madi, Sicong Ma, Alessa Mieg +6 more

764 citations

Omkar Chaudhary, Patricia Rodríguez-Morales, Xiaoli Sun, Dan Chen, Roberta Zappasodi +23 more